Benoit SR, Hora I, Albright AL, Gregg EW New directions in incidence and prevalence of diagnosed diabetes in the USA. BMJ Open Diabetes Res Care. 2019 May 28;7(1):e000657. doi: 10.1136/bmjdrc-2019-000657. eCollection 2019.
Boughton CK, Munro N, Whyte M Targeting beta-cell preservation in the management of type 2 diabetes. British Journal of Diabetes and Vascular Disease. Published online 2017. doi:10.15277/bjd.2017.148
Chen C, Cohrs CM, Stertmann J, Bozsak R, Speier S Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis. Mol Metab. 2017 Jul 8;6(9):943-957. doi: 10.1016/j.molmet.2017.06.019. eCollection 2017 Sep. Review.
Cnop M, Hannaert JC, Grupping AY, Pipeleers DG Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification. Endocrinology. 2002 Sep;143(9):3449-53.
Diabetes and African Americans, CDC 2016 Summary Health Statistics: National Health Interview Survey: 2014. US Department of Health and Human Services, Office of Minority Health website. http://www.cdc.gov/nchs/nhis/shs/tables.htm
Economic Research Service Commodity consumption by population characteristics. United States Department of Agriculture. Published 2012. http://www.ers.usda.gov/data-products/commodity-consumption-by-population-characteristics.aspx
Indaram M, Ma W, Zhao L, Fariss RN, Rodriguez IR, Wong WT 7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degeneration. Sci Rep. 2015 Mar 16;5:9144. doi: 10.1038/srep09144.
J V. Vicente S, Sampaio G, Ferrari C, Torres E. Oxidation of Cholesterol in Foods and Its Importance for Human Health. Vol 28.; 2012. doi:10.1080/87559129.2011.594972
Kahleova H, Fleeman R, Hlozkova A, Holubkov R, Barnard ND A plant-based diet in overweight individuals in a 16-week randomized clinical trial: metabolic benefits of plant protein. Nutr Diabetes. 2018 Nov 2;8(1):58. doi: 10.1038/s41387-018-0067-4.
Kahleova H, Tura A, Hill M, Holubkov R, Barnard ND A Plant-Based Dietary Intervention Improves Beta-Cell Function and Insulin Resistance in Overweight Adults: A 16-Week Randomized Clinical Trial. Nutrients. 2018 Feb 9;10(2). pii: E189. doi: 10.3390/nu10020189.
Linseisen J, Wolfram G Absorption of cholesterol oxidation products from ordinary foodstuff in humans. Ann Nutr Metab. 1998;42(4):221-30.
Lyons MA, Samman S, Gatto L, Brown AJ Rapid hepatic metabolism of 7-ketocholesterol in vivo: implications for dietary oxysterols. J Lipid Res. 1999 Oct;40(10):1846-57.
Mehta SP, Jarvis A, Standifer D, Warnimont C International physical activity questionnaire. Critical Reviews in Physical and Rehabilitation Medicine. Published online 2018. doi:10.1615/CritRevPhysRehabilMed.2018026180
Morel DW, Lin CY Cellular biochemistry of oxysterols derived from the diet or oxidation in vivo. Journal of Nutritional Biochemistry. Published online 1996. doi:10.1016/0955-2863(96)00101-5
Report NDS National Diabetes Statistics Report, 2020. National Diabetes Statistics Report. Published online 2020.
RISE Consortium Lack of Durable Improvements in ß-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. Diabetes Care. 2019 Sep;42(9):1742-1751. doi: 10.2337/dc19-0556. Epub 2019 Jun 9.
Rodriguez-Estrada MT, Garcia-Llatas G, Lagarda MJ 7-Ketocholesterol as marker of cholesterol oxidation in model and food systems: when and how. Biochem Biophys Res Commun. 2014 Apr 11;446(3):792-7. doi: 10.1016/j.bbrc.2014.02.098. Epub 2014 Feb 28. Review.
Saisho Y An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective. Expert Opin Pharmacother. 2020 Sep;21(13):1565-1578. doi: 10.1080/14656566.2020.1776262. Epub 2020 Jun 10. Review.
Saisho Y Importance of Beta Cell Function for the Treatment of Type 2 Diabetes. J Clin Med. 2014 Aug 14;3(3):923-43. doi: 10.3390/jcm3030923. Review.
Standl E The importance of beta-cell management in type 2 diabetes. Int J Clin Pract Suppl. 2007 Jun;(153):10-9. Review.
Staprans I, Pan XM, Rapp JH, Feingold KR The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis. Mol Nutr Food Res. 2005 Nov;49(11):1075-82. Review.
Wang J, Wang H Oxidative Stress in Pancreatic Beta Cell Regeneration. Oxid Med Cell Longev. 2017;2017:1930261. doi: 10.1155/2017/1930261. Epub 2017 Aug 3. Review.
Weigel TK, Kulas JA, Ferris HA Oxidized cholesterol species as signaling molecules in the brain: diabetes and Alzheimer's disease. Neuronal Signal. 2019 Dec;3(4):NS20190068. doi: 10.1042/NS20190068. Epub 2019 Nov 28. Review.
Zmyslowski A, Szterk A Oxysterols as a biomarker in diseases. Clin Chim Acta. 2019 Apr;491:103-113. doi: 10.1016/j.cca.2019.01.022. Epub 2019 Jan 24. Review.
Dietary Oxysterols and β-Cell Function Among African Americans
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.